Literature DB >> 1534286

Familial lipoprotein disorders in patients with premature coronary artery disease.

J J Genest1, S S Martin-Munley, J R McNamara, J M Ordovas, J Jenner, R H Myers, S R Silberman, P W Wilson, D N Salem, E J Schaefer.   

Abstract

BACKGROUND: Genetic lipoprotein disorders have been associated with premature coronary artery disease (CAD). METHODS AND
RESULTS: The prevalence of such disorders was determined in 102 kindreds (n = 603 subjects) in whom the proband had significant CAD documented by angiography before the age of 60 years. Fasting plasma cholesterol, triglyceride, low density lipoprotein (LDL) cholesterol, apolipoprotein (apo) B, and lipoprotein (a) [Lp(a)] values above the 90th percentile and high density lipoprotein (HDL) cholesterol and apo A-I below the 10th percentile of age- and sex-specific norms were defined as abnormal. An abnormality was noted in 73.5% of probands compared with 38.2% in age-matched controls (p less than 0.001), with a low HDL cholesterol level (hypoalphalipoproteinemia) being the most common abnormality (39.2% of cases). In these kindreds, 54% had a defined phenotypic familial lipoprotein or apolipoprotein disorder. The following frequencies were observed: Lp(a) excess, 18.6% (includes 12.7% with no other dyslipidemias); hypertriglyceridemia with hypoalphalipoproteinemia, 14.7%; combined hyperlipidemia, 13.7% (11.7% with and 2.0% without hypoalphalipoproteinemia); hyperapobetalipoproteinemia (elevated apo B only), 5%; hypoalphalipoproteinemia, 4%; hypercholesterolemia (elevated LDL only), 3%; hypertriglyceridemia, 1%; decreased apo A-I only, 1%. Overall, 54% of the probands had a familial dyslipidemia; unclassifiable lipid disorders (spouse also affected) were found in 3%. No identifiable familial dyslipidemia was noted in 43% of kindreds of those; nearly half (45%) had a sporadic lipid disorder. Parent-offspring and proband-spouse correlations for these biochemical variables revealed that lipoprotein and apolipoprotein levels are in part genetically determined, with Lp(a) showing the highest degree of parent-offspring correlation.
CONCLUSIONS: Our data indicate that more than half of patients with premature CAD have a familial lipoprotein disorder, with Lp(a) excess, hypertriglyceridemia with hypoalphalipoproteinemia, and combined hyperlipidemia with hypoalphalipoproteinemia being the most common abnormalities.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534286     DOI: 10.1161/01.cir.85.6.2025

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  97 in total

Review 1.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

2.  Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish families.

Authors:  Aino Soro; Päivi Pajukanta; Heidi E Lilja; Kati Ylitalo; Tero Hiekkalinna; Markus Perola; Rita M Cantor; Jorma S A Viikari; Marja-Riitta Taskinen; Leena Peltonen
Journal:  Am J Hum Genet       Date:  2002-03-12       Impact factor: 11.025

Review 3.  Screening relatives of patients with premature coronary heart disease.

Authors:  Gilbert R Thompson
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

Review 4.  Cardiovascular consequences of obese and nonobese obstructive sleep apnea.

Authors:  Kannan Ramar; Sean M Caples
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

Review 5.  The physiology of lipoproteins.

Authors:  Thomas N Tulenko; Anne E Sumner
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

6.  Evidence of linkage of HDL level variation to APOC3 in two samples with different ascertainment.

Authors:  France Gagnon; Gail P Jarvik; Arno G Motulsky; Samir S Deeb; John D Brunzell; Ellen M Wijsman
Journal:  Hum Genet       Date:  2003-08-29       Impact factor: 4.132

7.  Family coronary heart disease: a call to action.

Authors:  H Robert Superko; Robert Roberts; Brenda Garrett; Lakshmana Pendyala; Spencer King
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

8.  Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.

Authors:  P Pajukanta; J D Terwilliger; M Perola; T Hiekkalinna; I Nuotio; P Ellonen; M Parkkonen; J Hartiala; K Ylitalo; J Pihlajamäki; K Porkka; M Laakso; J Viikari; C Ehnholm; M R Taskinen; L Peltonen
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

9.  Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.

Authors:  Leonardo De Luca; Marcello Arca; Pier L Temporelli; Furio Colivicchi; Lucio Gonzini; Donata Lucci; Biagio Bosco; Mariella Callerame; Giulio V Lettica; Andrea Di Lenarda; Michele M Gulizia
Journal:  Clin Cardiol       Date:  2018-08-20       Impact factor: 2.882

10.  Glucose-6-Phosphate Dehydrogenase Deficiency is Associated with Cardiovascular Disease in U.S. Military Centers.

Authors:  John E Thomas; Seungho Kang; Charles J Wyatt; Forest S Kim; A David Mangelsdorff; Fred K Weigel
Journal:  Tex Heart Inst J       Date:  2018-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.